{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:53:54Z","timestamp":1763535234633},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-3305-6-199","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T16:22:35Z","timestamp":1373041355000},"source":"Crossref","is-referenced-by-count":29,"title":["Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection"],"prefix":"10.1186","volume":"6","author":[{"given":"Yasmeen M","family":"Attia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essam F","family":"Elalkamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat A","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheir S","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman S","family":"El-Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"1003_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1756-3305-4-234","volume":"4","author":"DH Molyneux","year":"2011","unstructured":"Molyneux DH, Malecela MN: Neglected tropical diseases and the millennium development goals: why the \"other diseases\" matter: reality versus rhetoric. Parasit Vectors. 2011, 4: 234-10.1186\/1756-3305-4-234.","journal-title":"Parasit Vectors"},{"key":"1003_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0001-706X(02)00045-1","volume":"82","author":"D Engels","year":"2002","unstructured":"Engels D, Chitsulo L, Montresor A, Savioli L: The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop. 2002, 82: 139-146. 10.1016\/S0001-706X(02)00045-1.","journal-title":"Acta Trop"},{"key":"1003_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1756-3305-5-108","volume":"5","author":"AM Ahmed","year":"2012","unstructured":"Ahmed AM, Abbas H, Mansour FA, Gasim GI, Adam I: Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel. Parasit Vectors. 2012, 5: 108-10.1186\/1756-3305-5-108.","journal-title":"Parasit Vectors"},{"key":"1003_CR4","first-page":"189","volume":"44","author":"B Gryseels","year":"1992","unstructured":"Gryseels B: Morbidity due to infection with Schistosoma mansoni: an update. Trop Geogr Med. 1992, 44: 189-200.","journal-title":"Trop Geogr Med"},{"key":"1003_CR5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1086\/314999","volume":"180","author":"Q Mohamed-Ali","year":"1999","unstructured":"Mohamed-Ali Q, Elwali N, Abdelhameed A, Mergani A, Rahoud S, Elagib K, Saeed O, Abel L, Magzoub M, Dessein A: Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis. 1999, 180: 1298-1306. 10.1086\/314999.","journal-title":"J Infect Dis"},{"key":"1003_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/egh.11.92","volume":"6","author":"F Tacke","year":"2012","unstructured":"Tacke F, Weiskirchen R: Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol. 2012, 6: 67-80. 10.1586\/egh.11.92.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1003_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA: Liver fibrosis. J Clin Invest. 2005, 115: 209-218.","journal-title":"J Clin Invest"},{"key":"1003_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/hep.510260440","volume":"26","author":"MJ Arthur","year":"1997","unstructured":"Arthur MJ: Matrix degradation in liver: a role in injury and repair. Hepatology. 1997, 26: 1069-1071.","journal-title":"Hepatology"},{"key":"1003_CR9","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/j.1365-3156.2009.02387.x","volume":"14","author":"M Loebermann","year":"2009","unstructured":"Loebermann M, Sombetzki M, Langner C, Fuchsbichler A, Gumhold J, Silbert D, Riebold D, Holtfreter M, Fickert P, Nizze H, Trauner M, Reisinger EC: Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis. Trop Med Int Health. 2009, 14: 1418-1425. 10.1111\/j.1365-3156.2009.02387.x.","journal-title":"Trop Med Int Health"},{"key":"1003_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0168-8278(99)80007-5","volume":"30","author":"T Knittel","year":"1999","unstructured":"Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G: Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol. 1999, 30: 48-60. 10.1016\/S0168-8278(99)80007-5.","journal-title":"J Hepatol"},{"key":"1003_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1699-0463.1999.tb01524.x","volume":"107","author":"G Murphy","year":"1999","unstructured":"Murphy G, Stanton H, Cowell S, Butler G, Kn\u00e4uper V, Atkinson S, Gavrilovic J: Mechanisms for pro matrix metalloproteinase activation. APMIS. 1999, 107: 38-44.","journal-title":"APMIS"},{"key":"1003_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","volume":"125","author":"R Bataller","year":"2003","unstructured":"Bataller R, Sancho-Bru P, Gin\u00e8s P, Lora JM, Al-Garawi A, Sol\u00e9 M, Colmenero J, Nicol\u00e1s JM, Jim\u00e9nez W, Weich N, Guti\u00e9rrez-Ramos JC, Arroyo V, Rod\u00e9s J: Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology. 2003, 125: 117-125. 10.1016\/S0016-5085(03)00695-4.","journal-title":"Gastroenterology"},{"key":"1003_CR13","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1053\/gast.2002.36561","volume":"123","author":"G Paizis","year":"2002","unstructured":"Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM, Angus PW: Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology. 2002, 123: 1667-1676. 10.1053\/gast.2002.36561.","journal-title":"Gastroenterology"},{"key":"1003_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","volume":"118","author":"R Bataller","year":"2000","unstructured":"Bataller R, Gin\u00e8s P, Nicol\u00e1s JM, G\u00f6rbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rod\u00e9s J: Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology. 2000, 118: 1149-1156. 10.1016\/S0016-5085(00)70368-4.","journal-title":"Gastroenterology"},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1074\/jbc.M310284200","volume":"279","author":"S Hazra","year":"2004","unstructured":"Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, Tsukamoto H: Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem. 2004, 279: 11392-11401. 10.1074\/jbc.M310284200.","journal-title":"J Biol Chem"},{"key":"1003_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.biocel.2010.02.006","volume":"42","author":"J Yu","year":"2010","unstructured":"Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J, Wu CW, Tong L, Zhao J, Poon TC, Sung JJ: Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro. Int J Biochem Cell Biol. 2010, 42: 948-957. 10.1016\/j.biocel.2010.02.006.","journal-title":"Int J Biochem Cell Biol"},{"key":"1003_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mehy.2004.09.015","volume":"64","author":"S Yamagishi","year":"2005","unstructured":"Yamagishi S, Takeuchi M: Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. Med Hypotheses. 2005, 64: 476-478. 10.1016\/j.mehy.2004.09.015.","journal-title":"Med Hypotheses"},{"key":"1003_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/ajh.2008.27","volume":"2","author":"N Kobayashi","year":"2008","unstructured":"Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H: Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Am J Hypertens. 2008, 2: 576-581.","journal-title":"Am J Hypertens"},{"key":"1003_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.1962.11.201","volume":"11","author":"J Pellegrino","year":"1962","unstructured":"Pellegrino J, Oliveira CA, Faria J, Cunha AS: New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg. 1962, 11: 201-215.","journal-title":"Am J Trop Med Hyg"},{"key":"1003_CR20","first-page":"132","volume":"16","author":"JC Holanda","year":"1974","unstructured":"Holanda JC, Pellegrino J, Gazzinelli G: Infection of mice with cercariae and schistosomula of Schistosoma mansoni by intravenous and subcutaneous routes. Rev Inst Med Trop Sao Paulo. 1974, 16: 132-134.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1003_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00389899","volume":"52","author":"R G\u00f6nnert","year":"1977","unstructured":"G\u00f6nnert R, Andrews P: Praziquantel, a new broad-spectrum antischistosomal agent. Z Parasitenkd. 1977, 52: 129-150. 10.1007\/BF00389899.","journal-title":"Z Parasitenkd"},{"key":"1003_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejphar.2009.04.042","volume":"614","author":"Z Halici","year":"2009","unstructured":"Halici Z, Bilen H, Albayrak F, Uyanik A, Cetinkaya R, Suleyman H, Keles ON, Unal B: Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?. Eur J Pharmacol. 2009, 614: 146-152. 10.1016\/j.ejphar.2009.04.042.","journal-title":"Eur J Pharmacol"},{"key":"1003_CR23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4269\/ajtmh.1967.16.483","volume":"16","author":"RH Duvall","year":"1967","unstructured":"Duvall RH, DeWitt WB: An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am J Trop Med Hyg. 1967, 16: 483-486.","journal-title":"Am J Trop Med Hyg"},{"key":"1003_CR24","first-page":"711","volume":"41","author":"von Lichtenberg","year":"1962","unstructured":"von Lichtenberg : Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am J Pathol. 1962, 41: 711-731.","journal-title":"Am J Pathol"},{"key":"1003_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1590\/S0074-02762003000700011","volume":"98","author":"EM Coutinho","year":"2003","unstructured":"Coutinho EM, Barros AF, Barbosa A, Oliveira SA, Silva LM, Ara\u00fajo RE, Andrade ZA: Host nutritional status as a contributory factor to the remodeling of schistosomal hepatic fibrosis. Mem Inst Oswaldo Cruz. 2003, 98: 919-925.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1003_CR26","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/29.11.6172466","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine L: Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem. 1981, 29: 1349-1353. 10.1177\/29.11.6172466.","journal-title":"J Histochem Cytochem"},{"key":"1003_CR27","first-page":"237","volume":"55","author":"FA Sinicrope","year":"1995","unstructured":"Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995, 55: 237-241.","journal-title":"Cancer Res"},{"key":"1003_CR28","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.3748\/wjg.14.2905","volume":"14","author":"H Chen","year":"2008","unstructured":"Chen H, He YW, Liu WQ, Zhang JH: Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. World J Gastroenterol. 2008, 14: 2905-2911. 10.3748\/wjg.14.2905.","journal-title":"World J Gastroenterol"},{"key":"1003_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0167-5699(00)01626-1","volume":"21","author":"AW Cheever","year":"2000","unstructured":"Cheever AW, Hoffmann KF, Wynn TA: Immunopathology of schistosomiasis mansoni in mice and men. Immunol Today. 2000, 21: 46-466.","journal-title":"Immunol Today"},{"key":"1003_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1053\/gast.2001.25480","volume":"121","author":"JR Jonsson","year":"2001","unstructured":"Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE: Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology. 2001, 121: 148-155. 10.1053\/gast.2001.25480.","journal-title":"Gastroenterology"},{"key":"1003_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/jhep.2001.28231","volume":"34","author":"H Yoshiji","year":"2001","unstructured":"Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H: Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 2001, 34: 745-750. 10.1053\/jhep.2001.28231.","journal-title":"Hepatology"},{"key":"1003_CR32","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","volume":"139","author":"N Kurikawa","year":"2003","unstructured":"Kurikawa N, Suga M, Kuroda S, Yamada K, Ishikawa H: An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol. 2003, 139: 1085-1094. 10.1038\/sj.bjp.0705339.","journal-title":"Br J Pharmacol"},{"key":"1003_CR33","first-page":"877","volume":"23","author":"AF El-Fakahany","year":"1993","unstructured":"El-Fakahany AF, Abdalla KF, El-Hady HM, Abd E, Aziz SM, Afifi LM: The effect of praziquantel treatment on the liver functions, worm burden, and granuloma size using two drug regimen in murine Schistosoma mansoni infection. J Egypt Soc Parasitol. 1993, 23: 877-886.","journal-title":"J Egypt Soc Parasitol"},{"key":"1003_CR34","first-page":"294","volume":"52","author":"MR Mahmoud","year":"2002","unstructured":"Mahmoud MR, Zoheiry MM, Nosseir MM: Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis. Arzneimittelforschung. 2002, 52: 294-301.","journal-title":"Arzneimittelforschung"},{"key":"1003_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.exppara.2009.04.006","volume":"122","author":"MM Helmy","year":"2009","unstructured":"Helmy MM, Mahmoud SS, Fahmy ZH: Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziquantel. Exp Parasitol. 2009, 122: 310-317. 10.1016\/j.exppara.2009.04.006.","journal-title":"Exp Parasitol"},{"key":"1003_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1440-1681.2011.05575.x","volume":"38","author":"NM El-Lakkany","year":"2011","unstructured":"El-Lakkany NM, El-Maadawy W, Ain-Shoka A, Badawy A, Hammam O, Ebeid F: Potential antifibrotic effects of AT1 receptor antagonist, losartan, and\/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni. Clin Exp Pharmacol Physiol. 2011, 38: 695-704. 10.1111\/j.1440-1681.2011.05575.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1003_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1471-4892(02)00139-X","volume":"2","author":"LF Ferder","year":"2002","unstructured":"Ferder LF, Inserra F, Basso N: Advances in our understanding of aging: role of the renin-angiotensin system. Curr Opin Pharmacol. 2002, 2: 189-194. 10.1016\/S1471-4892(02)00139-X.","journal-title":"Curr Opin Pharmacol"},{"key":"1003_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00034983.1986.11812004","volume":"80","author":"SS Botros","year":"1986","unstructured":"Botros SS, el-Badrawy N, Metwally AA, Khayyal MT: Study of some immunopharmacological properties of praziquantel in experimental schistosomiasis mansoni. Ann Trop Med Parasitol. 1986, 80: 189-196.","journal-title":"Ann Trop Med Parasitol"},{"key":"1003_CR39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00029330-200705010-00011","volume":"120","author":"Y Cheng","year":"2007","unstructured":"Cheng Y, Ping J, Xu LM: Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation\/redistribution in culture-activated rat hepatic stellate cells. Chin Med J (Engl.). 2007, 120: 794-801.","journal-title":"Chin Med J (Engl.)"},{"key":"1003_CR40","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","volume":"279","author":"MJ Arthur","year":"2000","unstructured":"Arthur MJ: Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2000, 279: G245-G249.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1003_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1478-3231.2004.0946.x","volume":"24","author":"X Zhou","year":"2004","unstructured":"Zhou X, Hovell CJ, Pawley S, Hutchings MI, Arthur MJ, Iredale JP, Benyon RC: Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int. 2004, 24: 492-501. 10.1111\/j.1478-3231.2004.0946.x.","journal-title":"Liver Int"},{"key":"1003_CR42","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ: Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998, 102: 538-549. 10.1172\/JCI1018.","journal-title":"J Clin Invest"},{"key":"1003_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.0019-2805.2004.01817.x","volume":"111","author":"KP Singh","year":"2004","unstructured":"Singh KP, Gerard HC, Hudson AP, Boros DL: Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology. 2004, 111: 343-352. 10.1111\/j.0019-2805.2004.01817.x.","journal-title":"Immunology"},{"key":"1003_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1600-0463.2007.apm_501.x","volume":"115","author":"N El-Lakkany","year":"2007","unstructured":"El-Lakkany N, Nosseir M: Pharmacodynamics of pentoxifylline and\/or praziquantel in murine schistosomiasis mansoni. APMIS. 2007, 115: 184-194. 10.1111\/j.1600-0463.2007.apm_501.x.","journal-title":"APMIS"},{"key":"1003_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1756-3305-5-9","volume":"5","author":"NM El-Lakkany","year":"2012","unstructured":"El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA: Anti-inflammatory\/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasit Vectors. 2012, 5: 9-10.1186\/1756-3305-5-9.","journal-title":"Parasit Vectors"},{"key":"1003_CR46","doi-asserted-by":"publisher","first-page":"e20247","DOI":"10.1371\/journal.pone.0020247","volume":"6","author":"YJ Liang","year":"2011","unstructured":"Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, Zhou Y, Chen AL, Ren YY, Sun KY, Sun Y, Wang Y, Zhang ZS: New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One. 2011, 6: e20247-10.1371\/journal.pone.0020247.","journal-title":"PLoS One"}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-3305-6-199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-3305-6-199\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-3305-6-199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T08:33:49Z","timestamp":1564562029000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/1756-3305-6-199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1186\/1756-3305-6-199","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]},"article-number":"199"}}